GL1X · GenesisL1 explorer

Ligand · 2Y7

2Y7 · (S)-2-((1-(2-(3-(2-fluoroethoxy)-4-methoxyphenyl)-5-methylthiazol-4-yl)ethyl)thio)pyrimidine-4,6-diamine

2Y7, (S)-2-((1-(2-(3-(2-fluoroethoxy)-4-methoxyphenyl)-5-methylthiazol-4-yl)ethyl)thio)pyrimidine-4,6-diamine (C19 H22 F N5 O2 S2, 435.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…

Component
2Y7
Formula
C19 H22 F N5 O2 S2
Class
ligand
Structures
2
PDB entries
1

Binding sites

2Y7 in 2 structures; the first of them:

  • 4Q1E · Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 10… · 2Y7 A302 · binds ILE30, SER59, LEU82, TYR86, ARG194, GLU196, GLU197, GLY199 and 3 more
  • 4Q1E · Human dck C4S-S74E mutant in complex with udp and the inhibitor 10 {2… · 2Y7 A302 · binds ILE30, SER59, LEU82, TYR86, ARG194, GLU196, GLU197, GLY199 and 3 more

Residues it binds most

GLU 4, ILE 4, TYR 4, ARG 4, GLY 4, LEU 4, PRO 4, SER 4 (residue and the binding sites it lines).

Found with

  • 2Y8 · (R)-2-((1-(2-(3-(2-fluoroethoxy)-4-methoxyphenyl)-5-methylthiazol-4-yl)ethyl)thio)pyrimidine-4,6-diamine
  • UDP · Uridine-5'-diphosphate

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.